life science

Amgen (NASDAQ:AMGN) today announced the presentation of new data across its rare disease portfolio and pipeline at…
Read More...

"Real-world evidence on chronic lesion formation and durability is critical as use of PFA for the treatment of Afib…
Read More...

Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that the United States…
Read More...

Financial Results Delivered record revenues of $95,573, an increase of $5,668 or 6% over the same period in prior…
Read More...